Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/jRCT1070240018
jRCT1070240018Not yet recruitingNot Applicable

Research on communication support for children with severe physical disabilities (aac)

Kumamoto Health Science University Reseach Grant Number 2024-C-010 sites20 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
20
Primary Endpoint
-
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Single Arm Study
Intervention Model
Single Assignment
Primary Purpose
Other
Masking
Open(masking Not Used)

Eligibility Criteria

Ages
No limit to No limit (—)

Inclusion Criteria

  • •individuals with SMID

Exclusion Criteria

  • •poor condition

Outcomes

Primary Outcomes

-

Milestone for spinal muscular atrophy type

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Kumamoto Health Science University Reseach Grant Number 2024-C-01

Similar Trials

Active, not recruiting
Phase 1
A trial to investigate the effect of acalabrutinib on skin prick test wheal size in adults with grass pollen allergy
CTIS2023-505783-11-00Alk-Abello A/S12
Active, not recruiting
Phase 1
/AMedDRA version: 19.1Level: LLTClassification code 10036921Term: Prostate carcinomaSystem Organ Class: 100000004864
EUCTR2016-001361-81-FRINSTITUT DE CANCEROLOGIE DE L'OUEST
Active, not recruiting
Phase 1
/A
EUCTR2012-004053-88-FIJustus Liebig University, Giesses2,200
Active, not recruiting
Phase 1
/A
EUCTR2011-004552-19-FRHospices Civils de Lyon
Active, not recruiting
Not Applicable
/AChemotherapy Induced Nausea and Vomiting (CINV) 0 Moderately Emetogenic Chemotherapy (MEC)
EUCTR2004-001020-20-ATGlaxoSmithKline Group of Companies708